Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Healthstream (HSTM) over the last 17 years, with Q3 2025 value amounting to $85.7 million.

  • Healthstream's Current Deferred Revenue rose 331.33% to $85.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.7 million, marking a year-over-year increase of 331.33%. This contributed to the annual value of $84.2 million for FY2024, which is 72.23% up from last year.
  • Healthstream's Current Deferred Revenue amounted to $85.7 million in Q3 2025, which was up 331.33% from $88.4 million recorded in Q2 2025.
  • In the past 5 years, Healthstream's Current Deferred Revenue ranged from a high of $102.0 million in Q1 2025 and a low of $73.8 million during Q4 2021
  • Its 5-year average for Current Deferred Revenue is $85.1 million, with a median of $83.6 million in 2023.
  • The largest annual percentage gain for Healthstream's Current Deferred Revenue in the last 5 years was 2213.62% (2021), contrasted with its biggest fall of 906.67% (2021).
  • Quarter analysis of 5 years shows Healthstream's Current Deferred Revenue stood at $73.8 million in 2021, then increased by 7.66% to $79.5 million in 2022, then grew by 5.23% to $83.6 million in 2023, then rose by 0.72% to $84.2 million in 2024, then increased by 1.73% to $85.7 million in 2025.
  • Its Current Deferred Revenue stands at $85.7 million for Q3 2025, versus $88.4 million for Q2 2025 and $102.0 million for Q1 2025.